Clinical Trials
All Clinical Trials - Page 24 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT05151484Phase 4Active Not Recruiting
Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover
Teriparatide
- NCT05553093Phase 4Recruiting
Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes
Tirzepatide
- NCT05254418Phase 2Completed
Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease
Dulaglutide
- NCT05662189N/ARecruiting
Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus
Exenatide
- NCT04889183Phase 3Completed
SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes
Semaglutide
- NCT05249881EARLY_Phase 1Unknown
"Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."
Semaglutide
- NCT05285397N/AUnknown
Effect of Liraglutide on Weight Loss in Patients Who Have Undergone Revisional Bariatric Surgeries.
Liraglutide
- NCT04862143Phase 2Terminated
Pilot Decentralized Clinical Trial in Men and Pre and Post-menopausal Women With Breast Cancer and a Specific Mutation (PIK3CA) Treated With Alpelisib in Combination With Fulvestrant
Gonadorelin
- NCT04966741Phase 3Completed
Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity
Setmelanotide
- NCT05168774Phase 1/Phase 2Completed
FRDA Investigator Initiated Study (IIS) With Elamipretide
Elamipretide
- NCT05439499Phase 3Unknown
This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.
Gonadorelin
- NCT06301191N/AUnknown
The Effect of Semaglutide on Cardiovascular Markers and Liver Function
Semaglutide
- NCT07539584N/ACompleted
Adiponectin in Patients With Metabolic Disorders
Semaglutide
- NCT05122377N/ACompleted
RWE About QOL and Compliance of Patients With OFS in China
Gonadorelin
- NCT05131893N/ANot Yet Recruiting
Neoadjuvant Treatment of Breast Cancer
Gonadorelin
- NCT05253066Phase 2/Phase 3Unknown
Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer
Gonadorelin
- NCT05199714N/ACompleted
A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes
Pramlintide
- NCT05164614Phase 1Completed
Study Evaluating PK of PTH Administered Orally Via RaniPill™ Capsule
Teriparatide
- NCT04854083Phase 4Unknown
Semaglutide as an Adjunct to Dieting in the Treatment of Type 2 Diabetes
Semaglutide
- NCT07457424N/AActive Not Recruiting
Direct Measurement of Microstructure of Ingestive Behaviour After Initiation of GLP-1 Receptor Agonist Treatment at Maximum Dose (DIGRAT)
Semaglutide
- NCT05251207N/ACompleted
Plasma Trimethylamine N-oxide Elevation Induced by L-carnitine Supplementation and Insulin Resistance
Dsip
- NCT05227196Phase 1Completed
A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy People
Semaglutide
- NCT05136287N/ACompleted
SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECTIVE AND MULTICENTER STUDY. SEVERAL STUDY.
Semaglutide
- NCT05774119N/ACompleted
Effect of Coffee Consumption on Appetite Traits in Overweight and Obesity
Ghrp-6
- NCT04938388Phase 4Terminated
Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care
Semaglutide
- NCT05218915Phase 4Completed
Basal Plus GLP1-ra on Glycemic Variability in CKD
Dulaglutide
- NCT04894188N/ARecruiting
Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer
Gonadorelin
- NCT05268627N/AUnknown
Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss
Liraglutide
- NCT05114590Phase 4Completed
Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Very Uncontrolled Type 2 Diabetes Mellitus
Lixisenatide
- NCT04883606N/ACompleted
A Study With Teduglutide (Revestive®) in Adults With Short Bowl Syndrome
Teduglutide
- NCT04487925Phase 4Unknown
Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders
Gonadorelin
- NCT05189457Phase 2Active Not Recruiting
First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer
Gonadorelin
- NCT05232708Phase 1Completed
A Clinical Trial Looking at the Comparability of 2 Different Forms of Semaglutide
Semaglutide
- NCT05368857Phase 1Completed
DNA Repair Capacity of Afamelanotide on Ultraviolet Radiation-induced DNA Damage in Healthy Volunteers
Afamelanotide
- NCT04307797Phase 4Completed
Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants with Type 2 Diabetes
Exenatide
- NCT06229899N/ACompleted
Follistatin Levels in Metabolically Healthy and Unhealthy Obese Individuals
Follistatin
- NCT04873050Phase 4Recruiting
Treatment to Regress to Normoglycemia in Women with a Recent History of GDM
Semaglutide
- NCT05740488N/AUnknown
Efficacy and Safety of Apalutamide in Combination With 89Sr as Neoadjuvant Therapy in Prostate Cancer With ≤10 Bone Metastases
Gonadorelin
- NCT05027308Phase 3Completed
A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or Older
Teduglutide
- NCT06118203N/ACompleted
Semaglutide Use in Acute Pulmonary Embolism
Semaglutide
- NCT04979130Phase 4Completed
Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)
Semaglutide
- NCT05054361N/ARecruiting
Crosstalk Between Mucosal-Associated Invariant T (MAIT) Cells and the Gut Microbiota and Mucosa in the Development of Type 1 Diabetes in Children
Ll-37
- NCT05184374N/AUnknown
Efficacy of Prolonged GnRH Test in Male Adolescents With Postoperative HH
Gonadorelin
- NCT06020456N/ACompleted
Genetic Factors of the Desmopressin Response in Carriers of Hemophilia A
Desmopressin
- NCT05194124Phase 3Completed
Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Participants With Specific Gene Defects in the MC4R Pathway
Setmelanotide
- NCT05153772Phase 2Active Not Recruiting
Targeted Alpha-emitter Therapy of PRRT Naïve and Previous PRRT Neuroendocrine Tumor Patients
Octreotide
- NCT04919226Phase 3Active Not Recruiting
Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE
Octreotide
- NCT04989946Phase 1/Phase 2Active Not Recruiting
Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer
Gonadorelin
- NCT05857085Phase 4Completed
Novel Therapeutics and Endothelial Dysfunction in T1DM Patients
Semaglutide
- NCT04522622Phase 4Recruiting
Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
Teriparatide